Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""International journal of cancer [Int J Cancer] NLMUID: 0042124"" wg kryterium: JN


Tytuł:
Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis.
Autorzy:
Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Pedersen K; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
Sy S; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Tropé A; Section for Cervical Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Engesaeter B; Section for Cervical Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Kim JJ; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Burger EA; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1073-1081. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/diagnosis
Uterine Cervical Neoplasms*/prevention & control
Papillomavirus Infections*/diagnosis
Papillomavirus Infections*/prevention & control
Papillomavirus Infections*/epidemiology
Adolescent ; Pregnancy ; Female ; Humans ; Adult ; Human Papillomavirus Viruses ; Cost-Benefit Analysis ; Human papillomavirus 16/genetics ; Triage ; Early Detection of Cancer ; Human papillomavirus 18/genetics ; Colposcopy ; Norway
Czasopismo naukowe
Tytuł:
A noninvasive multianalytical approach establishment for risk assessment and gastric cancer screening.
Autorzy:
Fan XH; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.
Zhang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Munich, Germany.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Beijing, China.
Wang P; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Song QQ; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang M; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Munich, Germany.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Beijing, China.; Technical University of Munich (TUM), School of Medicine, Institute for Medical Microbiology, Immunology and Hygiene, Munich, Germany.; German Center for Infection Research, Munich, Germany.
Mejias-Luque R; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Munich, Germany.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Beijing, China.; Technical University of Munich (TUM), School of Medicine, Institute for Medical Microbiology, Immunology and Hygiene, Munich, Germany.; German Center for Infection Research, Munich, Germany.
Li ZX; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Munich, Germany.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Beijing, China.
Zhou T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.
Zhang JY; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.
Liu WD; Linqu County Public Health Bureau, Linqu, China.
Zhang LF; Linqu County People's Hospital, Linqu, China.
Li WQ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Munich, Germany.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Beijing, China.
You WC; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Munich, Germany.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Beijing, China.
Gerhard M; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Munich, Germany.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Beijing, China.; Technical University of Munich (TUM), School of Medicine, Institute for Medical Microbiology, Immunology and Hygiene, Munich, Germany.; German Center for Infection Research, Munich, Germany.
Jiao YC; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang XB; State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pan KF; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Munich, Germany.; PYLOTUM Key Joint Laboratory for Upper GI Cancer, Technische Universität München/Peking University Cancer Hospital & Institute, Beijing, China.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1111-1123. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/diagnosis
Stomach Neoplasms*/genetics
Stomach Neoplasms*/pathology
Helicobacter pylori*/genetics
Helicobacter Infections*/diagnosis
Helicobacter Infections*/genetics
Helicobacter Infections*/pathology
Humans ; DNA Methylation ; Early Detection of Cancer ; Biomarkers ; Risk Assessment ; Biomarkers, Tumor/genetics ; CpG Islands
Czasopismo naukowe
Tytuł:
Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016-2018.
Autorzy:
Tulsidás S; Medical Oncology Service, Maputo Central Hospital, Maputo, Mozambique.; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Universidade do Porto, Porto, Portugal.
Fontes F; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Universidade do Porto, Porto, Portugal.; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.; Oncology Nursing Research Unit IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Centre (Porto.CCC) & (Health Research Network), Porto, Portugal.
Monteiro K; Medical Oncology Service, Maputo Central Hospital, Maputo, Mozambique.
Mussa M; Department of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
Lovane L; Department of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.; Pathology Service, Maputo Central Hospital, Maputo, Mozambique.
Morais AG; Radiotherapy Service, Maputo Central Hospital, Maputo, Mozambique.
Brandão M; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.; Department of Medical Oncology, Institut Jules Bordet-Hôpital Universitaire de Bruxelles, Brussels, Belgium.
Lunet N; EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal.; Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Universidade do Porto, Porto, Portugal.; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Carrilho C; Department of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.; Pathology Service, Maputo Central Hospital, Maputo, Mozambique.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1019-1028. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/epidemiology
Uterine Cervical Neoplasms*/therapy
Humans ; Female ; Mozambique/epidemiology ; Prognosis ; Survival Analysis ; Hospitals ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł:
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Autorzy:
Rossari F; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Tada T; Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan.
Suda G; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
Yoo C; Department of Oncology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Cheon J; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Finkelmeier F; Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Lim HY; Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, Korea.
Presa J; Liver Unit-CHTMAD, Vila Real, Portugal.
Masi G; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Bergamo F; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Amadeo E; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Vitiello F; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Kumada T; Department of Nursing, Gifu Kyoritsu University, Japan.
Sakamoto N; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Aoki T; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
Chon HJ; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Himmelsbach V; Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Iavarone M; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico di Milano, Division of Gastroenterology and Hepatology, Milan, Italy.
Cabibbo G; Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties PROMISE, University of Palermo, Palermo, Italy.
Montes M; Liver Unit-CHTMAD, Vila Real, Portugal.
Foschi FG; Department of Internal Medicine, Ospedale di Faenza, Faenza, Italy.
Vivaldi C; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy.; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Soldà C; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Sho T; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Niizeki T; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Nishida N; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
Steup C; Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Hirooka M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
Kariyama K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
Tani J; Department of Gastroenterology and Hepatology, Kagawa University, Kagawa, Japan.
Atsukawa M; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Takaguchi K; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Itobayashi E; Department of Gastroenterology, Asahi General Hospital, Asahi, Japan.
Fukunishi S; Department of Gastroenterology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Tsuji K; Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
Ishikawa T; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Tajiri K; Department of Gastroenterology, Toyama University Hospital, Toyama, Japan.
Ochi H; Hepato-biliary Center, Japanese Red Cross Matsuyama Hospital, Matsuyama, Japan.
Yasuda S; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
Toyoda H; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
Ogawa C; Department of Gastroenterology, Japanese Red Cross Takamatsu Hospital, Takamatsu, Japan.
Nishimura T; Department of Internal medicine, Division of Gastroenterology and Hepatology, Hyogo Medical University, Nishinomiya, Japan.
Hatanaka T; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Maebashi, Japan.
Kakizaki S; Department of Clinical Research, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan.
Shimada N; Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan.
Kawata K; Department of Hepatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Tada F; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Ohama H; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Nouso K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
Morishita A; Department of Gastroenterology and Hepatology, Kagawa University, Kagawa, Japan.
Tsutsui A; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Nagano T; Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Itokawa N; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Okubo T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Imai M; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
Kosaka H; Department of Surgery, Kansai Medical University, Osaka, Japan.
Naganuma A; Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan.
Koizumi Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
Nakamura S; Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan.
Kaibori M; Department of Surgery, Kansai Medical University, Osaka, Japan.
Iijima H; Department of Internal medicine, Division of Gastroenterology and Hepatology, Hyogo Medical University, Nishinomiya, Japan.
Hiasa Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
Persano M; Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy.
Burgio V; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Piscaglia F; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Scartozzi M; Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy.
Cascinu S; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Casadei-Gardini A; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Rimini M; Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1043-1056. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Phenylurea Compounds*
Quinolines*
Antibodies, Monoclonal, Humanized*
Humans ; Bevacizumab/therapeutic use ; Prospective Studies
Czasopismo naukowe
Tytuł:
Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
Autorzy:
Rijken A; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
Pape M; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Amsterdam UMC location University of Amsterdam, Medical Oncology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
Simkens GA; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.; Department of Surgery and Cancer, Imperial College London, London, UK.
de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; GROW-School for Oncology and Development Biology, Maastricht University, Maastricht, the Netherlands.
Luyer MDP; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
van Sandick JW; Department of Surgery, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands.
van Laarhoven HWM; Amsterdam UMC location University of Amsterdam, Medical Oncology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
Verhoeven RHA; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Amsterdam UMC location University of Amsterdam, Medical Oncology, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands.
van Erning FN; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 992-1002. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Peritoneal Neoplasms*/epidemiology
Peritoneal Neoplasms*/therapy
Stomach Neoplasms*/epidemiology
Stomach Neoplasms*/therapy
Humans ; Incidence ; Netherlands/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Impact of the COVID-19 pandemic on delivery of prostate cancer care in Australia: An interrupted time series analysis.
Autorzy:
Ng Hung Shin B; Department of Urology, Princess Alexandra Hospital, The University of Queensland, Brisbane, QLD, Australia.
Tan S; Department of Urology, Princess Alexandra Hospital, The University of Queensland, Brisbane, QLD, Australia.
Rhee H; Department of Urology, Princess Alexandra Hospital, The University of Queensland, Brisbane, QLD, Australia.
Chung E; Department of Urology, Princess Alexandra Hospital, The University of Queensland, Brisbane, QLD, Australia.; AndroUrology Centre, Brisbane, QLD, Australia.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1003-1010. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/therapy
Prostatic Neoplasms*/pathology
COVID-19*/epidemiology
Aged ; Male ; Humans ; Prostate-Specific Antigen ; Prostate/pathology ; Interrupted Time Series Analysis ; Pandemics ; Androgen Antagonists ; Prostatectomy ; Australia/epidemiology ; National Health Programs
Czasopismo naukowe
Tytuł:
High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020.
Autorzy:
Boni SP; PAC-CI Research Program, Abidjan, Côte d'Ivoire.; National Cancer Control Program, Abidjan, Côte d'Ivoire.
Tenet V; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Horo A; Gynecology and Obstetrics Department, University Hospital of Yopougon, Abidjan, Côte d'Ivoire.
Heideman DAM; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Bleeker MCG; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Tanon A; Infectious and Tropical Diseases Department, University Hospital of Treichville, Abidjan, Côte d'Ivoire.
Mian B; Gynecology and Obstetrics Department, University Hospital of Cocody, Abidjan, Côte d'Ivoire.
Mohenou ID; Pathology Department, University Hospital of Cocody, Abidjan, Côte d'Ivoire.
Ekouevi DK; PAC-CI Research Program, Abidjan, Côte d'Ivoire.; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, Bordeaux, France.; Faculté des Sciences de la Santé, Département de Santé Publique, Université de Lomé, Lomé, Togo.
Gheit T; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Didi-Kouko Coulibaly J; Alassane Ouattara National Center of Oncology and Radiotherapy (CNRAO), Abidjan, Côte d'Ivoire.
Tchounga BK; Elizabeth Glazer Paediatric AIDS Foundation, Yaoundé, Cameroon.
Adoubi I; National Cancer Control Program, Abidjan, Côte d'Ivoire.; Oncology Department, University Hospital of Treichville, Abidjan, Côte d'Ivoire.
Clifford GM; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Jaquet A; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, Bordeaux, France.
Pokaż więcej
Corporate Authors:
on behalf The IeDEA West Africa Collaboration
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 962-968. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/epidemiology
Papillomavirus Infections*/complications
Papillomavirus Infections*/epidemiology
HIV Infections*/complications
HIV Infections*/epidemiology
Human Papillomavirus Viruses*
Alphapapillomavirus*
Female ; Humans ; Middle Aged ; Cote d'Ivoire/epidemiology ; Human papillomavirus 18 ; Human papillomavirus 16 ; HIV ; Prevalence
SCR Organism:
human papillomavirus 45; human papillomavirus 35
Czasopismo naukowe
Tytuł:
Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
Autorzy:
Du Y; Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li Q; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chang X; Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shen K; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang H; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xing S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 969-978. Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, B-Cell, Marginal Zone*/epidemiology
Lymphoma, B-Cell, Marginal Zone*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/pathology
Leukemia, Lymphocytic, Chronic, B-Cell*
Humans
Czasopismo naukowe
Tytuł:
Inhibition of the Cyclin K-CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer.
Autorzy:
Frei K; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Schecher S; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Daher T; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Hörner N; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Richter J; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Hildebrand U; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Schindeldecker M; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; Tissue Biobank of the University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Witzel HR; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Tsaur I; Department of Urology and Pediatric Urology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Porubsky S; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Gaida MM; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Roth W; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Tagscherer KE; Institute of Pathology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1082-1096. Date of Electronic Publication: 2023 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/pathology
Anilides*
Pyrimidines*
Male ; Humans ; Androgen Antagonists/pharmacology ; Androgen Antagonists/therapeutic use ; Androgens ; Retrospective Studies ; DNA Damage ; Cyclins/genetics ; Cyclin-Dependent Kinases
Czasopismo naukowe
Tytuł:
Fast proliferating and slowly migrating non-small cell lung cancer cells are vulnerable to decitabine and retinoic acid combinatorial treatment.
Autorzy:
Pelos G; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Riester M; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Pal J; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Myacheva K; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, A Partnership Between DKFZ and University Medical Center Freiburg, Freiburg, Germany.
Moneke I; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Rotondo JC; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Lübbert M; Department of Internal Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Diederichs S; Division of Cancer Research, Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, A Partnership Between DKFZ and University Medical Center Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1029-1042. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Humans ; Aged ; Tretinoin/pharmacology ; Tretinoin/therapeutic use ; Decitabine/pharmacology ; Decitabine/therapeutic use ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Cell Line, Tumor ; Cell Proliferation
Czasopismo naukowe
Tytuł:
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanisms.
Autorzy:
Dinter L; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Karitzky PC; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.
Schulz A; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Wurm AA; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Department of Translational Medical Oncology, NCT Dresden, Dresden, Germany.; Mildred Scheel Early Career Center, NCT Dresden, Medical Faculty and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.
Mehnert MC; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Sergon M; Institute of Pathology, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.
Tunger A; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
Lesche M; DRESDEN-Concept Genome Center, Technology Platform at the Center for Molecular and Cellular Bioengineering (CMCB), TU Dresden, Dresden, Germany.
Wehner R; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Müller A; Medical Faculty, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Käubler T; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.
Niessner H; Department of Dermatology, Oncology, University Medical Center, Tübingen, Germany.
Dahl A; DRESDEN-Concept Genome Center, Technology Platform at the Center for Molecular and Cellular Bioengineering (CMCB), TU Dresden, Dresden, Germany.
Beissert S; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Schmitz M; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.; Skin Cancer Center at the University Cancer Center Dresden, University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.
Seliger B; Medical Faculty, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.; Institute of Translational Immunology, Medical School 'Theodor Fontane', Brandenburg an der Havel, Germany.; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
Westphal D; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, a partnership between German Cancer Research Center (DKFZ), Faculty of Medicine and University Hospital Carl Gustav Carus at TU Dresden, and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1057-1072. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/genetics
Melanoma*/metabolism
Humans ; Proto-Oncogene Proteins B-raf ; Vemurafenib ; Protein Kinase Inhibitors/adverse effects ; Mitogen-Activated Protein Kinase Kinases ; Mutation ; Drug Resistance, Neoplasm/genetics ; Membrane Proteins/genetics ; GTP Phosphohydrolases/genetics
Czasopismo naukowe
Tytuł:
Cancer-related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factors.
Autorzy:
Schmidt ME; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Maurer T; Department of Cancer Epidemiology, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Obi N; Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute for Occupational and Maritime Medicine Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Chang-Claude J; Department of Cancer Epidemiology, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Steindorf K; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1011-1018. Date of Electronic Publication: 2023 Nov 11.
Typ publikacji:
Journal Article
MeSH Terms:
Granulocyte-Macrophage Colony-Stimulating Factor*
Breast Neoplasms*/complications
Breast Neoplasms*/genetics
Humans ; Female ; Leptin ; Resistin ; Interleukin-6 ; Case-Control Studies ; Vascular Endothelial Growth Factor A ; Biomarkers ; Quality of Life
Czasopismo naukowe
Tytuł:
Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.
Autorzy:
Wilson NR; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan; Michigan Medicine, Ann Arbor, Michigan, USA.
Acikgoz Y; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Hasanov E; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 947-961. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Renal Cell*/drug therapy
Kidney Neoplasms*/pathology
Antineoplastic Agents*/therapeutic use
Humans ; Prognosis ; Biology
Czasopismo naukowe
Tytuł:
Peri-weaning cholera toxin consumption suppresses chemically-induced carcinogenesis in mice.
Autorzy:
Afaloniati H; Laboratory of Biochemistry and Toxicology, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Aindelis G; Department of Molecular Biology and Genetics, Democritus University of Thrace, University Campus Dragana, Alexandroupolis, Greece.
Spyridopoulou K; Department of Molecular Biology and Genetics, Democritus University of Thrace, University Campus Dragana, Alexandroupolis, Greece.
Lagou MK; Laboratory of Pathology, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Tsingotjidou A; Laboratory of Anatomy, Histology and Embryology, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Chlichlia K; Department of Molecular Biology and Genetics, Democritus University of Thrace, University Campus Dragana, Alexandroupolis, Greece.
Erdman SE; Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Poutahidis T; Laboratory of Pathology, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Angelopoulou K; Laboratory of Biochemistry and Toxicology, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1097-1110. Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
Vibrio cholerae*
Neoplasms*
Animals ; Mice ; Cholera Toxin ; Weaning ; Carcinogenesis/chemically induced
Czasopismo naukowe
Tytuł:
Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
Autorzy:
Madrigal JM; Occupational & Environmental Epidemiology Branch, Division of Cancer Epidemiology & Genetics (DCEG), National Cancer Institute (NCI), Rockville, Maryland, USA.
Troisi R; Trans-Divisional Research Program, DCEG, NCI, Rockville, Maryland, USA.
Surcel HM; Biobank Borealis of Northern Finland, Oulu University Hospital, Oulu, Finland.; Faculty of Medicine, University of Oulu, Oulu, Finland.
Öhman H; Biobank Borealis of Northern Finland, Oulu University Hospital, Oulu, Finland.; Faculty of Medicine, University of Oulu, Oulu, Finland.
Kivelä J; Biobank Borealis of Northern Finland, Oulu University Hospital, Oulu, Finland.; Faculty of Medicine, University of Oulu, Oulu, Finland.
Kiviranta H; Finnish Institute for Health and Welfare/Environmental Health Unit, Kuopio, Finland.
Rantakokko P; Finnish Institute for Health and Welfare/Environmental Health Unit, Kuopio, Finland.
Koponen J; Finnish Institute for Health and Welfare/Environmental Health Unit, Kuopio, Finland.
Medgyesi DN; Occupational & Environmental Epidemiology Branch, Division of Cancer Epidemiology & Genetics (DCEG), National Cancer Institute (NCI), Rockville, Maryland, USA.; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA.
Kitahara CM; Radiation Epidemiology Branch, DCEG, NCI, Rockville, Maryland, USA.
McGlynn KA; Metabolic Epidemiology Branch, DCEG, NCI, Rockville, Maryland, USA.
Sampson J; Biostatistics Branch, DCEG, NCI, Rockville, Maryland, USA.
Albert PS; Biostatistics Branch, DCEG, NCI, Rockville, Maryland, USA.
Ward MH; Occupational & Environmental Epidemiology Branch, Division of Cancer Epidemiology & Genetics (DCEG), National Cancer Institute (NCI), Rockville, Maryland, USA.
Jones RR; Occupational & Environmental Epidemiology Branch, Division of Cancer Epidemiology & Genetics (DCEG), National Cancer Institute (NCI), Rockville, Maryland, USA.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 979-991. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Environmental Pollutants*
Fluorocarbons*/adverse effects
Thyroid Neoplasms*/epidemiology
Thyroid Neoplasms*/etiology
Sulfonic Acids*
Alkanesulfonic Acids*
Humans ; Female ; Pregnancy ; Thyroid Cancer, Papillary/epidemiology ; Case-Control Studies ; Finland/epidemiology
Czasopismo naukowe
Tytuł:
Systemic versus localized Bacillus Calmette Guérin immunotherapy of bladder cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
Autorzy:
Atallah A; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Grossman A; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Nauman RW; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Paré JF; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Khan A; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Siemens DR; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.; Department of Urology, Queen's University, Kingston, Ontario, Canada.
Cotechini T; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.
Graham CH; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada.; Department of Urology, Queen's University, Kingston, Ontario, Canada.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 14. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004-2015: A comparative population-based study.
Autorzy:
Peirelinck H; Belgian Cancer Registry, Brussels, Belgium.
Schulpen M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Hoogendijk R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Van Damme A; Department of Pediatric Hematology and Oncology, Saint Luc University Hospital, Brussels, Belgium.
Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Utrecht, Utrecht, The Netherlands.
Henau K; Belgian Cancer Registry, Brussels, Belgium.
Van Damme N; Belgian Cancer Registry, Brussels, Belgium.
Karim-Kos HE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 13. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Health utility values of breast cancer treatments and the impact of varying quality of life assumptions on cost-effectiveness.
Autorzy:
Kregting LM; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Vrancken Peeters NJMC; Academic Breast Cancer Center, Department of Oncologic and Gastro-intestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Clarijs ME; Academic Breast Cancer Center, Department of Oncologic and Gastro-intestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Koppert LB; Academic Breast Cancer Center, Department of Oncologic and Gastro-intestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Korfage IJ; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
van Ravesteyn NT; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 13. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Association of female reproductive and hormonal factors with gallbladder cancer risk in Asia: A pooled analysis of the Asia Cohort Consortium.
Autorzy:
Shin A; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.; Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Republic of Korea.; Medical Research Centre, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Cho S; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Medical Research Centre, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Abe SK; Division of Prevention, Centre for Public Health Sciences, National Cancer Centre Institute for Cancer Control, Tokyo, Japan.
Islam MR; Division of Prevention, Centre for Public Health Sciences, National Cancer Centre Institute for Cancer Control, Tokyo, Japan.; Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Tokyo, Japan.
Rahman MS; Division of Prevention, Centre for Public Health Sciences, National Cancer Centre Institute for Cancer Control, Tokyo, Japan.; Research Centre for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Saito E; Sustainable Society Design Center, Graduate School of Frontier Science, The University of Tokyo, Tokyo, Japan.
Kazmi SZ; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Katagiri R; Division of Cohort Research, National Cancer Centre, Institute for Cancer Control, Tokyo, Japan.; National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.
Merritt M; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
Choi JY; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Republic of Korea.
Shu XO; Division of Epidemiology, Vanderbilt-Ingram Cancer Centre, Vanderbilt Epidemiology Centre, Vanderbilt University Medical Centre, Nashville, Tennessee, USA.
Sawada N; Division of Cohort Research, National Cancer Centre, Institute for Cancer Control, Tokyo, Japan.
Tamakoshi A; Department of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Koh WP; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore, Singapore.
Sakata R; Radiation Effects Research Foundation, Hiroshima, Japan.
Hozawa A; Tohoku University Graduate School of Medicine, Miyagi Prefecture, Japan.
Kim J; Graduate School of Cancer Science and Policy, National Cancer Centre, Gyeonggi-do, Republic of Korea.
Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.; Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kweon SS; Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
Wen W; Division of Epidemiology, Vanderbilt-Ingram Cancer Centre, Vanderbilt Epidemiology Centre, Vanderbilt University Medical Centre, Nashville, Tennessee, USA.
Tsugane S; Division of Cohort Research, National Cancer Centre, Institute for Cancer Control, Tokyo, Japan.; Graduate School of Public Health, International University of Health and Welfare, Tokyo, Japan.
Kimura T; Department of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Yuan JM; Division of Cancer Control and Population Sciences, UPMC Hillman Cancer Centre, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kanemura S; Tohoku University Graduate School of Medicine, Miyagi Prefecture, Japan.
Sugawara Y; Tohoku University Graduate School of Medicine, Miyagi Prefecture, Japan.
Shin MH; Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.
Ahsan H; Department of Public Health Sciences, University of Chicago, Chicago, Illinois, USA.
Boffetta P; Stony Brook Cancer Centre, Stony Brook University, Stony Brook, New York, USA.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Chia KS; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Matsuo K; Division of Cancer Epidemiology and Prevention, Aichi Cancer Centre Research Institute, Nagoya, Japan.; Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Qiao YL; School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Rothman N; Division of Cancer Epidemiology & Genetics, Occupational and Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Maryland, USA.
Zheng W; Division of Epidemiology, Vanderbilt-Ingram Cancer Centre, Vanderbilt Epidemiology Centre, Vanderbilt University Medical Centre, Nashville, Tennessee, USA.
Inoue M; Division of Prevention, Centre for Public Health Sciences, National Cancer Centre Institute for Cancer Control, Tokyo, Japan.
Kang D; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 13. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Stage at diagnosis of colorectal cancer in the Middle East and Northern Africa: A population-based cancer registry study.
Autorzy:
Znaor A; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Eser S; Faculty of Medicine, Balikesir University, Balikesir, Türkiye.
Bendahhou K; Casablanca Cancer Registry, Casablanca, Morocco.
Shelpai W; National Cancer Registry, Dubai, United Arab Emirates.
Al Lawati N; Oman National Cancer Registry, Muscat, Oman.
ELBasmi A; Kuwait National Cancer Registry, Kuwait City, Kuwait.
Alemayehu EM; Qatar National Cancer Registry, Doha, Qatar.
Tazi MA; Rabat Cancer Registry, Rabat, Morocco.
Yakut C; Izmir Provincial Cancer Registry, Izmir, Türkiye.
Piñeros M; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 08. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies